Loader

Pathways

PathWhiz ID Pathway Meta Data

PW127551

Pw127551 View Pathway
drug action

Cefmetazole Action Pathway

Escherichia coli (strain K12)

PW144402

Pw144402 View Pathway
drug action

Cefmetazole Drug Metabolism Action Pathway

Homo sapiens

PW176943

Pw176943 View Pathway
drug action

Cefonicid Action Pathway

Escherichia coli
Cefonicid is a second-generation cephalosporin administered intravenously or intramuscularly. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections. Cefonicid exhibits an anti-bacterial mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW145376

Pw145376 View Pathway
drug action

Cefonicid Drug Metabolism Action Pathway

Homo sapiens

PW175993

Pw175993 View Pathway
metabolic

Cefonicid Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Cefonicid are predicted with biotransformer.

PW176944

Pw176944 View Pathway
drug action

Cefoperazone Action Pathway

Escherichia coli
Cefoperazone is a broad-spectrum cephalosporin antibiotic used for the treatment of bacterial infections in various locations, including the respiratory tract, abdomen, skin, and female genital tracts. Cefoperazone exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW145377

Pw145377 View Pathway
drug action

Cefoperazone Drug Metabolism Action Pathway

Homo sapiens

PW175994

Pw175994 View Pathway
metabolic

Cefoperazone Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Cefoperazone are predicted with biotransformer.

PW176958

Pw176958 View Pathway
drug action

Ceforanide Action Pathway

Escherichia coli
Ceforanide is a 1-β methyl-carbapenem that is structurally related to beta-lactam antibiotics.5 It was first authorized for use in the US in November 2001 and in Europe in April 2002. Shown to be effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria, ertapenem is used to treat various bacterial infections. Ceforanide exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs).5 In Escherichia coli, it has a strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preferential binding to PBPs 2 and 3.5 Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW145024

Pw145024 View Pathway
drug action

Ceforanide Drug Metabolism Action Pathway

Homo sapiens